Edilia Tapia

Edilia Tapia

Auto-generated profile, based on publicly available information

Edilia Tapia

Department of Nephrology, 2Department of Pathology and 3Department of Immunology, lnstituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2006 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
PBPablo Bautista-García
Pablo Bautista-García
LLLaura Gabriela Sanchez Lozada
Laura Gabriela Sanchez Lozada
MCMagdalena Cristóbal-García
Magdalena Cristóbal-García
ETEdilia Tapia
Edilia Tapia
VSVirgilia Soto
Virgilia Soto
JHJaime Herrera-Acosta
Jaime Herrera-Acosta
Background. Chronic renal damage is associated with inflammatory infiltration, fibrosis and vascular lesion, coupled with increased expression of cyclo-oxygenase 2 (COX-2) and transforming growth factor-β1 (TGF-β1). However, the role of inducible nitric oxide synthase (NOS-2) is still controversial. Thus, we studied the contribution of NOS-2 to the expression levels of COX-2 and TGF-β1, as well as the structural renal injury in rats with subtotal renal ablation (5/6 Nx).

1 January 2008 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Open access
PDF file
MFMartha Franco
Martha Franco
RBRocio Bautista
Rocio Bautista
OPOscar Pérez-Méndez
Oscar Pérez-Méndez
LGLidia González
Lidia González
UPUrsino Pacheco
Ursino Pacheco
FMFlavio Martínez
Flavio Martínez
Since marked renal vasoconstriction is observed in angiotensin II (ANG II)-mediated hypertensive rats, we studied the possible interaction between ANG II and adenosine in this model. ANG II was infused into male Wistar rats through osmotic minipumps (435 ng·kg−1·min−1) for 14 days. In sham and ANG II groups, renal tissue and interstitial adenosine were measured; both increased to a similar twofold extent in the ANG II-treated rats (31.40 ± 4 vs. 62.0 ± 8.4 nM, sham vs. ANG II, interstitial adenosine; P< 0.001). The latter decreased by 47% with the specific blockade of 5′-nucleotidase. Glomerular hemodynamics demonstrated marked renal vasoconstriction in the angiotensin-treated group, which was reverted by an adenosine A1-receptor antagonist (8-cyclopentyl-1,3-dipropylxanthine, 10 μg·kg−1·min−1). 5′-Nucleotidase and adenosine deaminase (ADA) activities were measured in the cytosolic and membrane fractions. Only the membrane ADA activity decreased from 1,202 ± 80 to 900 ± 50 mU/mg protein in the ANG II-treated rats ( P< 0.05), as well as in their protein and mRNA expression. Despite the adenosine elevation, A1and A2breceptor protein did not change; in contrast, downregulation was observed in A2areceptor and upregulation in A3receptor. A similar pattern was found in the cortex and in the medulla; mRNA significantly decreased only in the A3receptor in both segments. These results suggest that the elevation of renal tissue and interstitial adenosine contributes to the renal vasoconstriction observed in the ANG II-induced hypertension and that it is mediated by a decrease in the activity and expression of ADA, increased production of adenosine, and an induced imbalance in adenosine receptors.